Target intelligence / Profile preview

Mycobacterial protein secretion system (T7SS)

Target
T7SS
Molecular classification
Protein complex, Transporter, Enzyme
01

Overview

Mycobacterial protein secretion systems are complex specialized machineries, most notably the Type VII secretion systems (T7SS or ESX), that are essential for the survival and pathogenicity of Mycobacterium tuberculosis. These systems facilitate the transport of virulence effectors and essential proteins across the unique, lipid-rich mycobacterial cell envelope into the host environment. The ESX-1 system is particularly critical for virulence, as it enables the bacteria to escape the host macrophage phagosome and modulate immune signaling through the secretion of proteins like ESAT-6 and CFP-10. Other systems, such as ESX-3, are vital for maintaining metal ion homeostasis, including iron and zinc acquisition, which is necessary for bacterial growth. Because many components of these secretion systems are essential for viability or virulence but lack human homologs, they represent high-value targets for the development of novel anti-tubercular agents. Experimental compounds such as IMB-BZ and various MycP1 protease inhibitors are currently being investigated for their ability to specifically block these pathways without the broad-spectrum pressure of traditional antibiotics.

Other names
Type VII secretion systemESX secretion systemESAT-6 secretion systemMycobacterial protein export machinerySec/Tat secretion pathways
02

Mechanism of action

Inhibition of the secretion machinery (e.g., the ESX-1 translocon or MycP1 protease) to prevent the export of virulence effectors or essential proteins, thereby disarming bacterial pathogenicity and reducing survival within host macrophages.

03

Biological functions

Protein transportVirulencePhagosomal escapeImmune modulationMetal ion homeostasisCell wall integrity
04

Disease associations

Infection
05

Safety considerations

Bacterial resistance developmentSelectivity over host-cell transport mechanismsCytotoxicity of early-stage experimental inhibitorsPotential impact on beneficial commensal bacteria with similar conserved pathways
06

Interacting drugs

IMB-BZ

4 more in the full profile.

07

Biomarkers

Early secreted antigenic target 6 kDa (ESAT-6/EsxA)Culture filtrate protein 10 kDa (CFP-10/EsxB)EspBEspC

Beyond the preview

Go deeper on Mycobacterial protein secretion system (T7SS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial protein secretion system (T7SS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call